Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study to Assess the Comparative Bioavailability and Pharmacokinetics of Naproxen From OXP005 Tablets (Test) And Naprosyn Tablets (Reference) in Normal, Healthy, Adult Subjects

Next Previous
Search
Trial Profile

Study to Assess the Comparative Bioavailability and Pharmacokinetics of Naproxen From OXP005 Tablets (Test) And Naprosyn Tablets (Reference) in Normal, Healthy, Adult Subjects

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 14 May 2015

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Naproxen (Primary)
  • Indications Musculoskeletal pain
  • Focus Pharmacokinetics; Proof of concept
  • Sponsors Oxford Pharmascience

    • Most Recent Events

    • 13 May 2015 Positive full results of the pilot comparative pharmacokinetic study published in Oxford Pharmascience media release.
    • 27 Mar 2015 Primary endpoint has been met (comparative bioavailability of naproxen as measured by Tmax, Cmax, AUC, half-life), according to an Oxford Pharmascience media release.
    • 27 Mar 2015 Status changed from recruiting to completed, as reported in an Oxford Pharmascience media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top